Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Ottawa company says it plans to begin shipping the device “immediately” to federal and provincial governments as well as commercial customers.
After facing months of delays, Ottawa biotech firm is hoping its rapid testing device is poised to clear the final hurdle before it can go to market.
Company says it hopes to get Health Canada’s approval to market the test “in the coming weeks.”
Ottawa firm says it has applied to Health Canada to begin clinical trials on a fix for its rapid COVID-19 testing device after the agency had concerns about the test’s effectiveness.
An Ottawa-based biotech firm says Health Canada has given it the go-ahead to start shipping its rapid COVID-19 testing technology.
The federal government says a "limited selection" of edibles and other next-generation cannabis products will hit retail shelves no earlier than mid-December 2019
Health Canada is looking into whether two cannabis companies' sponsorship of a children's charity event last October is in violation of promotion restrictions within the Cannabis Act.
In response to Canada’s opioid crisis, the federal government has issued a $1 million challenge to find better ways to detect toxic substances — such as the highly potent fentanyl — in st
Canadians are eating out more and can expect to pay extra to do so in 2018, suggests a forward-looking report into food prices.